FirstTake on Pharma - Pharma News and Analysis Podcast podcast

The FirstTake Podcast – Does a paradigm shift in breast cancer beckon?

Manda indietro di 15 secondi
Manda avanti di 15 secondi
This week FirstWord Pharma PLUS editors Michael Flanagan, Virginia Li and Simon King discuss confirmation of positive top-line data for AstraZeneca and Daiichi Sankyo’s Enhertu in HER2 ‘low’ breast cancer, the implications stemming from Amicus Therapeutics’ decision to abort a gene-therapy spin out and whether GlaxoSmithKline and Sanofi’s long-awaited COVID-19 vaccine has arrived too late to make a meaningful impact on the pandemic.

Altri episodi di "FirstTake on Pharma - Pharma News and Analysis Podcast"